» Authors » Darlene C Deecher

Darlene C Deecher

Explore the profile of Darlene C Deecher including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 260
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gavrin L, Mahaney P, Jenkins D, Nogle L, Mugford C, Huselton C, et al.
ACS Med Chem Lett . 2014 Jun; 1(3):91-5. PMID: 24900182
The potency and selectivity of a series of 1-{(1S)-2-[amino]-1-[3-(trifluoromethoxy)phenyl]ethyl}cyclohexanol analogues are described. These compounds were prepared to improve in vitro metabolic stability and achieve brain penetration. Compound 13 (WAY-260022, NRI-022)...
2.
Insel R, Deecher D, Brewer J
Diabetes . 2011 Dec; 61(1):30-5. PMID: 22187372
No abstract available.
3.
ONeill D, Adedoyin A, Bray J, Deecher D, Fensome A, Goldberg J, et al.
J Med Chem . 2011 Sep; 54(19):6824-31. PMID: 21916421
Sequential modification of the previously identified 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols led to the identification of a new series of 1-(2-morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-dioxides that are potent and selective inhibitors of the norepinephrine transporter over both...
4.
ONeill D, Adedoyin A, Alfinito P, Bray J, Cosmi S, Deecher D, et al.
J Med Chem . 2010 May; 53(11):4511-21. PMID: 20462211
Structural modification of a virtual screening hit led to the identification of a new series of 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols which are potent and selective inhibitors of the norepinephrine transporter over both the...
5.
Sabatucci J, Mahaney P, Leiter J, Johnston G, Burroughs K, Cosmi S, et al.
Bioorg Med Chem Lett . 2010 Apr; 20(9):2809-12. PMID: 20378347
A series of heterocyclic cycloalkanol ethylamines have been prepared to expand our norepinephrine reuptake inhibitor (NRI) program. Synthesis of a variety of heterocycles identified (+)-S-21, a potent NRI efficacious in...
6.
Fensome A, Goldberg J, McComas C, Trybulski E, Woodworth R, Deecher D, et al.
Bioorg Med Chem Lett . 2010 Feb; 20(5):1555-8. PMID: 20153188
Two related series of selective norepinephrine reuptake inhibitors were synthesized based on 3,4-dihydro-1H-2,1,3-benzothiadiazine 2,2-dioxide or 3,4-dihydrosulfostyril cores, and screened for monoamine reuptake inhibition. Structure-activity relationships were determined for the series'...
7.
Vu A, Cohn S, Zhang P, Kim C, Mahaney P, Bray J, et al.
J Med Chem . 2010 Feb; 53(5):2051-62. PMID: 20131864
Efforts to identify new selective and potent norepinephrine reuptake inhibitors (NRIs) for multiple indications by structural modification of the previous 3-(arylamino)-3-phenylpropan-2-olamine scaffold led to the discovery of a novel series...
8.
Heffernan G, Coghlan R, Manas E, McDevitt R, Li Y, Mahaney P, et al.
Bioorg Med Chem . 2009 Oct; 17(22):7802-15. PMID: 19836247
The discovery of a series of 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles, dual acting norepinephrine reuptake inhibitors (NRIs) and 5-HT(2A) receptor antagonists, is described. The synthesis and structure-activity relationship (SAR) of this novel series of...
9.
Mahaney P, Kim C, Coghlan R, Cohn S, Heffernan G, Huselton C, et al.
Bioorg Med Chem Lett . 2009 Aug; 19(19):5807-10. PMID: 19713106
The SAR of a series of 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols as monoamine reuptake inhibitors, with a goal to improve both potency toward inhibiting the norepinephrine transporter and selectivity over the serotonin transporter, is...
10.
Kim C, Mahaney P, McConnell O, Zhang Y, Manas E, Ho D, et al.
Bioorg Med Chem Lett . 2009 Jul; 19(17):5029-32. PMID: 19632110
A novel series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols, have been discovered by combining virtual and focused screening efforts with design techniques. Synthesis of the two diastereomeric isomers of the...